Table 6.
Percent of cells on day 21 following the therapy, normalized to the initial levels before the therapy. Values above 100 indicate the cell counts have increased above the initial levels
| Patient number | Breast cancer stage | CD8 + perforin + T cells | CD123+ | CD11+ | CD25 + CD127– | ||||
|---|---|---|---|---|---|---|---|---|---|
| After the 1st round of chemotherapy | After the 3rd round of chemotherapy | After the 1st round of chemotherapy | After the 3rd round of chemotherapy | After the 1st round of chemotherapy | After the 3rd round of chemotherapy | After the 1st round of chemotherapy | After the 3rd round of chemotherapy | ||
| FAC chemotherapy + Placebo | |||||||||
| 02–12a | IIIA | 122.2 | 111.1 | 440.9 | 118.2 | 150.5 | 30.9 | 26.8 | 34.1 |
| 02–07 | IIIB | 46.7 | 105.6 | 80.0 | 176.7 | 43.8 | 200.0 | 220.8 | 54.7 |
| FAC chemotherapy + Panagen | |||||||||
| 02–02 | IIA | 300.0 | 420.0 | 92.3 | 615.4 | 92.9 | 333.3 | 1.1 | 81.8 |
| 02–10 | IIA | 178.6 | 178.6 | 543.8 | 37.5 | 666.7 | 83.3 | 120.0 | 62.0 |
| 02–03 | IIA | 100.0 | 23.3 | 61.4 | 59.1 | 41.1 | 41.1 | 4.5 | 116.7 |
| 02–11a | IIB | 123.5 | 58.8 | 310.3 | 34.5 | 66.1 | 14.0 | 16.7 | 133.3 |
| 02–15 | IIIA | 33.3 | 26.9 | 23.1 | 54.8 | 19.4 | 69.2 | 69.2 | |
| 02–05 | IIIB | 39.4 | 106.3 | 35.3 | 220.6 | 62.7 | 178.0 | 180.0 | 160.0 |
| 02–14 | IIIB | - | 153.8 | 123.1 | 97.7 | 85.2 | 127.3 | 118.2 | |
| 02–01 | IIIB | 200.0 | 525.0 | 263.0 | 42.0 | 150.0 | 42.0 | 200.0 | 200.0 |
| 02–08 | IIIB | 61.8 | 117.6 | 88.2 | 188.2 | 204.8 | 202.4 | 175.0 | 300.0 |
Note: a – tamoxifen treatment. Patients who progressed or died are shown in boldface